mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-08 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-08 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-07 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-07 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-07 |